Ionizing radiation is an important treatment modality for a variety of malignant conditions. However, development of radiation-induced skin changes is a significant adverse effect of radiation therapy (RT 
INTRODUCTION
Ionizing radiation (IR) is used to treat a variety of malignant conditions and is used to palliate metastatic disease. However, the development of radiation-induced skin changes is a significant adverse effect of radiation therapy (RT). Skin reactions to radiation are largely a function of technique, total dose, volume, and individual variations in treatment [1, 2] . While advances in technology and changes to therapeutic regimens have reduced the burden of cutaneous reactions to RT, radiation dermatitis remains a significant adverse effect of radiotherapy. of patients will experience a moderate to severe acute skin reaction in exposed areas [4] .
Severe acute reactions may lead to blistering, erosions, and ulceration [5] , which can lead to premature interruption of RT and potentially negatively influence cancer control and prognosis. Alternatively, the skin may appear relatively normal for months to years following RT, when chronic radiation dermatitis develops [3] . Chronic radiation dermatitis is permanent, progressive, and irreversible and has substantial impact on quality of life [5] . Thus, it is important for dermatologists to be able to recognize the adverse reactions to IR in order to assess the severity of disease and to assist in the management of these conditions. This review of cutaneous repercussions of RT is based on previously conducted studies and does not involve any new studies of human or animal subjects performed by the authors.
CLINICAL MANIFESTATIONS

Acute Radiation Dermatitis
Acute radiation dermatitis is one of the most common reactions to RT and usually occurs within 90 days of exposure. The severity of reaction ranges from mild erythema to moist desquamation and ulceration (Table 1 ) [6, 7] .
The reaction typically starts within 1-4 weeks after starting radiation treatment and persists during the radiation treatment period [8] . Acute radiation dermatitis is likely to heal with mild cutaneous changes.
The severity of disease can be graded on a scale of 1-4 according to the National Cancer Institute (Table 2) . Acute reactions start with erythema, edema, pigmentary changes and depilation that correlate with the amount of radiation exposure. Grade 1 changes include dry desquamation with a generalized erythema (Fig. 1) . Pruritus, epilation, scaling and depigmentation can also occur. With grade 2, there is brisk erythema or localized focal sloughing of the epidermis (Fig. 2) . These reactions lead to moist desquamation confined to the skin folds once the cumulative radiation dose reaches 40 Gy or more [9] . With moist desquamation, the epidermal layer is lost and there is a high propensity for infection. The reaction peaks in 1-2 weeks with subsequent healing. Patients can experience increased pain due to exposure of nerve endings. Grade 3 presents with extensive moist desquamation outside of skin folds (Fig. 3) . With grade 4, ulcerations, hemorrhage and skin necrosis occur that in some cases does not resolve, leading to the late-consequential changes of acute dermatitis that include ulcerations and fibrosis.
Reepithelialization usually starts within 10 days, but can be prolonged with exposure to radiosensitizing drugs especially platinum based chemotherapy. Additional findings that may occur with acute radiation dermatitis include comedo reactions of whiteheads and blackheads in head and neck cancers. 
Radiation Burns
Radiation burns, although rare with current treatment modalities, can occur with high-dose exposure to x-rays during interventional (Table 4) .
Post-inflammatory dyspigmentation is common, and, depending on the skin type of the patient and severity of the reaction, may slowly resolve or worsen over time [3] . The skin may become xerotic, scaly, and hyperkeratotic.
Significant cutaneous injury is characterized by persistent dyspigmentation, atrophy, and telangiectasia (Fig. 4 Once the skin has had sufficient opportunity to ''heal'' from radiation-induced injury, long-lasting cellular dysfunction and stromal changes remain that impair cutaneous integrity 
RISK FACTORS
A variety of factors that increase the risk of developing acute cutaneous reactions to IR have been identified (see Table 5 ). The severity of the reaction is related to both intrinsic and extrinsic factors. Extrinsic factors include the total dosage of radiation, fractioned delivery schedules, volume of irradiated tissue and the intrinsic radiosensitivity of the involved tissue
[48]. However, in general, moist intertriginous skin folds of the body are most susceptible.
These areas include the skin under the breast, axilla, head and neck, and the groin due to the ''bolus effect'', i.e. the propensity for higher doses of radiation to reach the skin folds [49] .
Extrinsic Factors
The total dose, dose/fraction, characteristics of the beam, volume and surface area of exposure to radiation all influence the degree of tissue damage [2, 3, [50] [51] [52] [53] . For example, the total radiation dose is an important factor in the development of skin toxicity. However, the total dose that leads to cutaneous skin 
Other Adjuvants
Oral Wobe-Mugus (a proteolytic enzyme mixture of 100 mg papain, 40 mg trypsin and 40 mg chymotrypsin) has been shown in two nonblinded RCTs versus no medication to decrease the odds for developing RT-induced skin toxicity by as much as 87% [89, 90] .
However, dosages and treatment schedule varied between studies. Other agents, including aloe vera, trolamine, sucralfate, and hyaluronic acid, do not have supportive evidence for use in the prevention of radiation dermatitis [91] [92] [93] [94] [95] [96] .
MANAGEMENT
Acute Cutaneous Reactions
Grade 1
Management is based principally on the severity of damaged skin. Patients with grade 1 radiation dermatitis are treated with nonspecific treatment similar to the aforementioned general prevention measures. Dry desquamation can be treated with hydrophilic moisturizers, while pruritus and irritation can be treated with low to mid potency steroids.
Grades 2 and 3
With more severe reactions involving moist desquamation (grades 2 and 3), treatment high-powered RCTs exist to date comparing these treatments [102] .
Grade 4
In severe skin reactions to RT (grade 4), there is significant full-thickness skin necrosis and ulceration. Treatment requires a multidisciplinary approach and discontinuation of RT. In addition, surgical debridement of necrotic tissues and the utilization of full-thickness skin grafts or pedicle flaps may be indicated. These high-grade cutaneous skin toxicity reactions can lead to late-consequential changes including fibrosis and non-healing ulcers, which have potential for malignant transformation.
Moreover, waves of inflammation can occur with radiation burns leading to the need for successive surgical excisions, reconstruction, and potential need for amputation [12, 13] .
Chronic Cutaneous Reactions
Unlike the majority of cases of acute cutaneous reactions to RT, chronic radiation dermatitis and radiation-induced fibrosis are unlikely to be self-repairing. Management of late cutaneous reactions of RT is reviewed in Table 8 .
Chronic Ulcerations and Wounds
As in acute radiation dermatitis, the care of ulcerations and wounds resulting from chronic radiation dermatitis is non-specific and follows [113] [114] [115] [116] . However, the results of the largest of these trials have met with mixed results. In these studies, patients treated with PTX in combination with vitamin E demonstrated marginal improvement in their condition, but treatment had little to no benefit over placebo [115, 116] . However, longer-term therapy may be an important element in the treatment of fibrosis. In a study of 44 women with superficial radiation-induced fibrosis treated with PTX and tocopherol over a range of 6-48 months, regression of superficial fibrosis was seen [117] . seen at 2-month follow up [119] . IFNc is an inflammatory cytokine that is thought to inhibit collagen production by fibroblasts [3] . Treatment with IFNc in 5 patients over a 1-year period was shown to be useful in the treatment of cutaneous fibrosis [120] . Hyperbaric oxygen has been evaluated as a treatment for radiation-induced fibrosis; however, there is insufficient evidence to show efficacy at this time [121] [122] [123] . Treatment may result in less pain, swelling, redness, or lymphedema, but no effect on fibrosis has been found [3, 124] . However, hyperbaric oxygen improves neutrophil function and has anti-bacterial effects, and thus may be considered as a guard against infection [3] . Laser therapy with epidermal grafting has also been explored as a novel approach to the treatment of radiation-induced fibrosis. In one case series, three Vietnamese children who had developed significant chronic radiation dermatitis and fibrosis from RT for infantile hemangiomas were treated with pulse-dye laser and/or fractional laser with epidermal skin grafting. The study authors reported skin softening, increased flexibility, repigmentation of the skin, and improvement of the telangiectasias, suggesting that this treatment modality should be explored further [118] . Treatment with pulse dye laser has been shown in case series to be beneficial [126] . In a retrospective study of breast cancer patients with radiation-induced telangiectasias, all 11 patients experienced clinical improvement with pulse dye laser, with an average clearance of 72.7% [127] .
Secondary Skin Cancers
Squamous cell carcinomas that arise in radiation fields exhibit aggressive behavior and more frequently metastasize, so surgical excision is the preferred modality for management 
FUTURE DIRECTIONS
The current advances in reducing cutaneous reactions have been primarily in the technological advancements of delivering increasingly targeted, homogenized RT utilizing fractionated schedules. The future will combine these advancements with targeted therapies for reducing the underlying inflammatory cascade, such as superoxide dismutase/catalase mimetics [130] , to decrease reactive oxygen species and interleukin inhibitors. Anti-oxidant properties of curcumin could be used to reduce radiation skin toxicity [131] . In addition, stem cell treatments to replace necrotic tissue after radiation burns
[12] and high-grade radiation dermatitis may become more readily available options. 
CONCLUSIONS
